Member Info for lordloadsoflolly

I take share tipsters with a pinch of salt, but an interesting article on H&T and Ramsdens nonetheless:

www.thisismoney.co.uk/money/investing/article-14627603/MIDAS-SHARE-TIPS-Unearth-beat-firms-set-profit-new-GOLD-RUSH.html

There are just under 98m Opti shares in issue, of which FYSCF held c. 4.7m at 6th Feb 2025.

So whilst any significant selling by them will have an impact, I suspect it’s unlikely to hold the SP down that much for that long.

Jenforluck - can't imagine ANYONE throwing a single coin into Tim's begging bowl if 2025 doesn't deliver.

It's now put up or shut up time, Tim.

Oldred7 - I don’t think we HAVE dealt with status of the revised P3 trial. Or the Avion partnership.

Simply saying it’s been overtaken by recent developments isn’t dealing with these issues.

Friedman - shouldn’t you be buying everyone a Diet Coke?!

Oldsharedog - I take it your post was a late April Fools:

“maybe Tiger is Tim's sibling ….. considering how much he knows”

Tigger doesn’t know his ar*e from his elbow. Or should I say his patient from his patent.

Martinu - it’s shown as an RNS on the London Stock Exchange:

www.londonstockexchange.com/stock/OPTI/optibiotix-health-plc/analysis

Good news, yet no mention of initial order volume or value.

Surely such basic info can’t be subject to an NDA?

Presumably it’s relatively small beer at this stage. But with another product launch in the pipeline, encouraging nonetheless.

Adyan - I wouldn't be TOO worried by that March SBTX sale.

SOH is still around 20% up, compared to Skin's current share price.

As for why he did it. Perhaps he simply foresaw SBTX rising on the launch news then falling on the launch date.

Or maybe, as you suggest, it's for working capital. Which is probably a good sign, assuming the sales orders are firm.

TW - that may just illustrate confirmation bias in Chat GPT/AI.

If you ask "could OPTI could ever be a bid play", you're implying you think it might (otherwise why ask).

So your friendly bot spews out possible reasons why it might come to pass.

That's not to say a takeover could never be on the cards. Simply that I wouldn't read TOO much into the answer you got.

It’s not too early to judge.

The man’s a meddling moron.

Anyone recall that poster on advfn’s board years ago who was always ramping IMM?

She claimed to work in a coffee shop in Malta or that neck of the woods, yet seemingly had £100,000s+ to throw at IMM.

Now I’m just wondering whether she swapped her cappuccino machine for a chemistry lab & rapidly retrained to become a PhD scientist.

Either way, the froth seems to be coming off IMM’s share price right now. Just as coffee shops are booming. Delonghi or Deshorti, that is the question.

Tigger - any idea where they’re registering the patient?

Our local GP surgery still has space if it would help.

Tigger - oh no. At least another 8 weeks+ eh?

Presumably the latest nod from your oh-so-reliable city chums (nudge nudge, drink drink)?

* boost, not boat!

This news (yet another Trump u-turn) will boat IQE’s opening SP on Monday:

www.bbc.co.uk/news/articles/c20xn626y81o.amp

Aquae - fair enough.

But regardless of who’s marketing Zenakine & what Boots are doing with No 7, it strikes me as a slightly muddled & questionable set of product benefits.

Customers normally respond best to a clear set of USPs with any new launch. Rather than claims that a skin product might a) improve their sleep AND b) make them happier AND c) errrr, actually make their skin look better & healthier too.

Maybe it’ll work, given the similar approach you say Boots has adopted. But the initial SBTX share price reaction suggests many are sceptical.

For now at least, SOH appears to have timed his latest holding reduction rather well.

3LB - you saying your "bell end alarm went off" has got my wife all excited.

She's now trawling through Amazon, trying to find one with next day delivery.

I sense a sinking of the Belgrano argument.

Of course SOH's sales haven't depressed SBTX's share price by 20p+. What utter nonsense.

SBTX's share price fell OVER A WEEK after the last Opti transaction.

Partly market-led (post- initial tariff implementation). Partly down to SBTX's bizarre RNS, marketing Zenakine as a product "taking sleep x Emotion x Skin health connection to a new level." That route's going to be a tough'un to explain & sell to your average Joe who mainly wants their skin to look healthier & less wrinkly.

Gotrader - you endlessly highlight the trades/shorts in IQE, repeatedly fretting about the potential pitfalls here.

Oh and you recently pointed out “If you are going to buy 10.4p is much better value than 17p”.

All very enlightening I must say.